India reported 61,408 new Covid-19 cases, 57,468 recoveries and 836 deaths in the last 24 hours. With this, the total Covid-19 tally rises to 31,06,349 including 23,38,036 cured/discharged/migrated cases & 57,542 deaths, according to the Union Ministry of Health.
With 61,408 new infections reported in the country, the tally has now risen to 31.06 lakh. Of these, 23,38,036 patients have already recovered, while 7,10,771 are still active.
The toll stands at 57,542 with 836 deaths reported in the last 24 hours. India’s coronavirus case tally crossed the 30 lakh-mark and settled at 30,44,940 on Saturday, 16 days after crossing the 20 lakh-mark and eight days after breaching the 25 lakh-mark.
Phase-2 clinical trials of the vaccine being developed by Oxford University and AstraZeneca would begin this week. The trials are being conducted by the Pune-based Serum Institute of India, which has an agreement with AstraZeneca to manufacture and market this vaccine for low and middle-income countries, including India.
Serum Institute of India (SSI), which has entered a manufacturing partnership with AstraZeneca to produce Oxford University’s Covid-19 vaccine candidate, has issued a clarification, denying reports that the shot may be launched in 73 days as “completely false and conjectural”.
The Pune-based company’s clarification said that the government has granted it permission to only manufacture Covishield and stockpile it for future use, according to news agency ANI. It has also said, according to ANI, that Covishield will be commercialised once trials are proven successful and requisite regulatory approvals are in place.
The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
“Our figures are being reconciled with the Indian Council of Medical Research,” the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.
According to the ICMR, a cumulative total of 3,59,02,137 samples have been tested up to August 23 with 6,09,917 samples being tested on Sunday.